|
RNF44 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.22489999999187E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.502500E-03 |
| Normal-vs-Stage2 |
4.104300E-03 |
| Normal-vs-Stage3 |
1.019510E-02 |
| Normal-vs-Stage4 |
4.621700E-03 |
| Stage1-vs-Stage2 |
1.307380E-01 |
| Stage1-vs-Stage3 |
2.258600E-01 |
| Stage1-vs-Stage4 |
1.056340E-02 |
| Stage2-vs-Stage3 |
7.344600E-01 |
| Stage2-vs-Stage4 |
2.146400E-01 |
| Stage3-vs-Stage4 |
1.505200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.446600E-04 |
| Normal-vs-AfricanAmerican |
1.575240E-03 |
| Normal-vs-Asian |
3.052200E-01 |
| Caucasian-vs-AfricanAmerican |
7.195000E-01 |
| Caucasian-vs-Asian |
6.391000E-01 |
| AfricanAmerican-vs-Asian |
7.458400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.01589999999641E-05 |
| Normal-vs-Female |
4.758000E-03 |
| Male-vs-Female |
5.540000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.064300E-02 |
| Normal-vs-Extreme_Weight |
7.001500E-03 |
| Normal-vs-Obese |
2.769500E-04 |
| Normal-vs-Extreme_Obese |
5.130300E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.749400E-01 |
| Normal_Weight-vs-Obese |
1.563850E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.073600E-01 |
| Extreme_Weight-vs-Obese |
2.195800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.230200E-01 |
| Obese-vs-Extreme_Obese |
9.936200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.624350E-02 |
| Normal-vs-Age(41-60Yrs) |
3.40040000046393E-07 |
| Normal-vs-Age(61-80Yrs) |
1.342340E-02 |
| Normal-vs-Age(81-100Yrs) |
3.454600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.370600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.289600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.562100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.564700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.499400E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.922800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.39690000000726E-05 |
| Normal-VS-Type2 PRCC |
1.096260E-03 |
| Normal-VS-KIRP CIMP |
2.621400E-01 |
| Normal-VS-Unclassified PRCC |
1.241180E-03 |
| Type1 PRCC-VS-Type2 PRCC |
8.118000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.222600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.185600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.919400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.983600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.742000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.707500E-02 |
| Normal-vs-N1 |
7.758300E-03 |
| Normal-vs-N2 |
9.641100E-04 |
| N0-vs-N1 |
9.078100E-02 |
| N0-vs-N2 |
1.114590E-01 |
| N1-vs-N2 |
7.215800E-01 |
|
|
